Less is Sometimes More in CAR-T Therapy

Alexander Salter, Stanley Riddell, and colleagues have discovered that cancer-killing chimeric antigen receptor (CAR)-T cells with stronger signaling capabilities are counterintuitively less effective against lymphoma cells in a mouse model. Credit: Robert Hood | Fred Hutch News Service Read more at Science Signaling: http://stke.sciencemag.org/lookup/doi...